Compare PACS & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PACS | PLXS |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | United States | United States |
| Employees | N/A | 20000 |
| Industry | | Electrical Products |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 5.3B |
| IPO Year | 2024 | 1995 |
| Metric | PACS | PLXS |
|---|---|---|
| Price | $33.98 | $192.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $45.50 | ★ $194.00 |
| AVG Volume (30 Days) | ★ 922.1K | 268.7K |
| Earning Date | 05-25-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 221.05 | 56.11 |
| EPS | 1.22 | ★ 1.51 |
| Revenue | ★ $5,288,932,000.00 | N/A |
| Revenue This Year | $10.04 | $14.26 |
| Revenue Next Year | $9.30 | $8.22 |
| P/E Ratio | ★ $28.25 | $129.30 |
| Revenue Growth | ★ 29.32 | N/A |
| 52 Week Low | $7.50 | $103.43 |
| 52 Week High | $43.08 | $211.84 |
| Indicator | PACS | PLXS |
|---|---|---|
| Relative Strength Index (RSI) | 39.95 | 48.76 |
| Support Level | $33.11 | $191.95 |
| Resistance Level | $35.10 | $209.97 |
| Average True Range (ATR) | 1.86 | 8.70 |
| MACD | -0.58 | -1.53 |
| Stochastic Oscillator | 9.59 | 42.50 |
PACS Group Inc is a post-acute healthcare company mainly focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.